Sponsor Pipeline

Energenesis Biomedical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05930210 A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer Diabetic Foot Ulcer Recruiting
Phase 2
NCT07647614 A Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's Disease Parkinson's Disease (PD) Not Yet Recruiting
Disease Areas
Get alerts when Energenesis Biomedical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free